Innospec (IOSP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
18 Feb, 2026Executive summary
Fourth quarter revenues were $466.8 million, down 6% year-over-year, with strong growth in Performance Chemicals and Fuel Specialties offsetting reduced Oilfield Services activity in Latin America.
Integration of the QGP acquisition in Brazil is progressing as planned, supporting regional growth.
Net loss of $70.4 million in Q4 was driven by a $155.6 million non-cash UK pension scheme settlement; adjusted non-GAAP EPS was $1.41 versus $1.84 last year.
Cash from operations for the quarter was $25.7 million; net cash position at year-end was $289.2 million.
Continued focus on innovation, cleaner fuels, and efficiency across all business lines.
Financial highlights
Q4 revenues were $466.8 million, down 6% year-over-year; gross margin decreased by 2.3 points to 29.2%.
Adjusted EBITDA for Q4 was $56.6 million versus $61.6 million last year; full year adjusted EBITDA rose 4% to $225.2 million.
Adjusted net income for Q4 was $46.3 million, up from $37.8 million; adjusted EPS for Q4 was $1.41 (vs. $1.84 last year); full-year adjusted EPS was $5.92 (vs. $6.09).
GAAP net loss for Q4 was $70.4 million due to a non-cash pension settlement charge; Q4 GAAP loss per share was $2.80.
Operating cash flow after capex for the year was $122.7 million; net cash increased to $289.2 million from $203.7 million a year ago.
Outlook and guidance
Targeting operating income and margin improvement in 2025 to levels consistent with 2022, especially in Performance Chemicals.
Expect continued growth in Performance Chemicals and Fuel Specialties, with sequential recovery in Oilfield Services in 2025.
Fuel Specialties to pursue growth in traditional, renewable, and non-fuel applications, focusing on margin improvement.
Oilfield Services not expecting recovery in Latin America production chemicals in coming quarters; focus shifts to US and Middle East opportunities.
Effective tax rate for 2025 expected to be around 27%.
Latest events from Innospec
- Double-digit sales and income growth, strong cash, and plant upgrades support future gains.IOSP
Q2 2026 - Revenue up 3% to $453.2M; dividend raised 10%; new $75M buyback amid mixed segment results.IOSP
Q1 2026 - Proxy covers director elections, executive pay, auditor ratification, and strong ESG performance.IOSP
Proxy filing - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting agenda.IOSP
Proxy filing - Net income rebounded sharply, margins improved, and net cash reached $292.5 million.IOSP
Q4 2025 - Board seeks approval for director elections, executive pay, and auditor, highlighting strong ESG progress.IOSP
Proxy Filing - Shareholders will vote on directors, executive pay, and auditor ratification at the May 2025 meeting.IOSP
Proxy Filing - Double-digit operating income growth, strong cash, and a 10% dividend hike despite lower sales.IOSP
Q3 2024 - Performance Chemicals and Fuel Specialties drove profit growth despite Oilfield Services weakness.IOSP
Q2 2024